Aroa Biosurgery Ltd

Aroa Biosurgery Ltd manufactures regenerative surgical bioscaffolds and extracellular matrix (ECM) products for soft tissue repair, wound management, and surgical reconstruction. The company's AROA ECM platform technology forms the foundation for a product portfolio addressing complex wounds, acute and chronic wound management, hernia repair, and abdominal wall reconstruction. Key products include Myriad Matrix (surgical soft tissue bioscaffold for complex wounds and reconstruction), Myriad Morcells (ECM-based product), Symphony (combination cellular and tissue product incorporating hyaluronic acid), Reinforced Bioscaffolds (hernia and abdominal wall applications), and Endoform (restorative bioscaffolds for acute and chronic wound management). The company serves clinicians, patients, investors, and distributors across both inpatient and outpatient healthcare settings. Aroa's product portfolio is designed to improve the rate and quality of soft tissue repair through biologically active scaffolding technology. The company markets its products internationally and maintains a focus on regenerative medicine applications in surgical specialties.